trending Market Intelligence /marketintelligence/en/news-insights/trending/in_depsqljn3oq07n9v3pa2 content esgSubNav
In This List

Albireo appoints CFO with pharma commercialization experience

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Albireo appoints CFO with pharma commercialization experience

Boston-based Albireo Pharma Inc. said Simon Harford will replace Tom Shea as the CFO and treasurer of the company.

Harford, who was previously senior vice president and CFO at PAREXEL International Corp., has more than three decades of experience, including in numerous senior leadership positions across finance and investor relations at GlaxoSmithKline PLC, Avon Products Inc. and Eli Lilly and Co. both in the U.S. and internationally.

Shea had been the CFO of the company since July 2016 and became the treasurer in November 2016.

Albireo Pharma develops bile acid treatments for liver and other gastrointestinal diseases.